National Biotechnology Conference

April 23-26

10:00 a.m - 6:00 p.m PT

Marriott Downtown, Philadelphia, PA 19107

We look forward to meeting with you at NBC.

Request a meeting with our scientific experts in Philadelphia, booth #916, to learn how we help our clients advance their drug modality.

Schedule a Meeting

Speak with our scientific experts onsite to discuss your project.

I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

I confirm that I am over the age of 16 and I consent to communications from BioAgilytix.

BioAgilytix Presentations at NBC

Hot Topic Panel Presentations:

Intro to Biomarkers: An Expert Panel Discussion

Panelist: Amanda Hays, PhD
Tuesday, April 25th
3:00 p.m – 4:00 p.m

Rapid Fire Presentations:

Considerations for Developing and Validating an Anti-AAV9 ADA Assay

Presenter: Sara Alhakeem, PhD
Monday, April 24th
2:45 p.m. – 3:00 p.m

qPCR Biodistribution and Shedding Assessment Strategy in Gene Therapy Studies

Presenter: Amanda Hays, PhD
Monday, April 24th
3:15 p.m – 3:30 p.m

Challenges in Developing Robust Hybridization Immunoassays

Presenter: Liz Nolff, MS
Wednesday, April 26th
2:45 p.m – 3:00 p.m

Poster Presentations:

Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay
to Quantify an Allogeneic Cell Product in Human Blood by ddPCR

Presenter: Brian D. Bower, PhD
Submission ID# 1452441

Accurately measure the immunogenicity and pharmacokinetics (PK) of your biotherapeutics and advanced modalities

We provide the global, best-in-class bioanalytical capabilities needed to address even the most challenging biomarker, immunogenicity, PK, and cell-based assay requirements.

Detect your drug product or it’s downstream effects with an experienced molecular assay partner

We have a proven track record working with biotherapeutics and advanced modalities. We have been successfully supporting these programs across a variety of delivery mechanisms and matrices for over 10 years.

Rely on services backed by global good manufacturing practices (GMP)

We offer a full suite of bioanalytical lifecycle services supporting the release, production, and manufacturing of therapeutic drugs. Our GMP-driven service offerings include immunoassays, cell-based assays, and molecular assays for potency assessments.

Access our vast biomarker experience to better understand the PD of your therapeutic

We offer a wide variety of off-the-shelf biomarker assays, including 120+ validated biomarker assays for a range of disease states.

Speak with our team about how the combination of world-class scientific expertise, outstanding project management, and superior regulatory insight can expedite your advanced therapeutic. You can also fill out the form, and an expert will reach out to schedule a meeting with you onsite.